XML 81 R53.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Business Combinations - Additional Information (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jan. 10, 2022
May 28, 2021
Mar. 31, 2022
Jun. 30, 2022
Sep. 30, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]                
Cash consideration     $ 18,201,000 $ 18,504,000 $ 18,504,000   $ 18,504,000 $ 15,000,000
Proceeds from revolving credit facility     $ 20,000,000 $ 20,000,000 $ 20,000,000   20,000,000  
Disior LTD.                
Business Acquisition [Line Items]                
Acquired percentage 100.00%              
Aggregate purchase price of acquisition $ 26,246,000              
Contingent earn-out consideration, estimated fair value 6,550,000              
Net working capital adjustments and deferred payments, net payable 222,000              
Cash consideration 19,696,000              
Maximum earn out payment 8,000,000              
Acquisition related costs           $ 0    
Business acquisition, pro forma information, description           There is no supplemental proforma presentation of operating results of the acquisition of Disior due to the immaterial impact on the Company’s Consolidated operations for the years ended December 31, 2022 and 2021.    
Net assets acquired 26,246,000              
Disior LTD. | Selling, General, and Administrative Expenses                
Business Acquisition [Line Items]                
Acquisition related costs             761,000  
Disior LTD. | Term Loan                
Business Acquisition [Line Items]                
Proceeds from revolving credit facility 20,000,000              
Disior LTD. | Measurement Period Adjustments                
Business Acquisition [Line Items]                
Aggregate purchase price of acquisition $ 26,246,000              
Additive Orthopaedics, LLC                
Business Acquisition [Line Items]                
Aggregate purchase price of acquisition   $ 17,870,000            
Contingent earn-out consideration, estimated fair value   2,870,000            
Cash consideration   15,000,000            
Maximum earn out payment   9,500,000            
Acquisition related costs           $ 0 $ 0  
Business acquisition, pro forma information, description           There is no supplemental proforma presentation of operating results of the acquisition of Additive due to the immaterial impact on the Company’s Consolidated operations for the years ended December 31, 2022 and 2021.    
Net assets acquired   $ 17,870,000            
Additive Orthopaedics, LLC | Selling, General, and Administrative Expenses                
Business Acquisition [Line Items]                
Acquisition related costs               $ 822,000